33.74USD+2.26%Mkt Cap: 1.26B USDP/E: —Last update: 2026-05-26
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segment…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap1.26B USD
Enterprise Value1.43B USD
Revenue (TTM)268.68M USD
Gross Profit204.37M USD
Net Income (TTM)-5.14M USD
Revenue/Share7.240 USD
Last Price33.74 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees373
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)12.31
PEG—
EV/EBITDA36.87
EV/Revenue5.33
P/S4.57
P/B42.81
EPS (TTM)-0.38
EPS (Forward)2.68
52W Range
25.2129% of range54.85
52W High54.85 USD
52W Low25.21 USD
Profitability
Gross Margin75.05%
Oper. Margin-49.95%
EBITDA Margin14.47%
Profit Margin-1.89%
ROE-9.80%
ROA-1.29%
Growth
Revenue Growth-7.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF43.86M USD
CapEx (TTM)1.10M USD
FCF Margin-1.88%
FCF Yield-0.40%
Net Debt204.69M USD
Net Debt/EBITDA5.27
Balance Sheet
Debt/Equity4.80
Current Ratio2.48
Quick Ratio2.16
Book Value/Sh0.7700 USD
Cash/Share2.575 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateFeb 8, 2013
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)67.75 USD
Target Range59.00 USD – 88.00 USD
# Analysts8
Ownership
Shares Out.37.28M
Float28.28M
Insiders15.47%
Institutions58.97%
Short Interest
Short Ratio13.2d
Short % Float19.35%
Short % Out.17.38%
Shares Short6.48M
Short (prev mo.)6.86M
Technical
SMA 5036.32 (-7.1%)
SMA 20041.32 (-18.3%)
Beta0.34
S&P 52W Chg28.31%
Avg Vol (30d)854.81K
Avg Vol (10d)1.49M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—